We are live on
!
Find out more
NCM
Northroad Capital Management Portfolio holdings
AUM
$43.8M
Turnover
28.3%
1-Year Est. Return
1.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+1.99%
3 Year Est. Return
+0.16%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$34.5M
(-16%)
Cap. Flow
-$44.4M
Cap. Flow
% of AUM
-23.77%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
59
New
5
Increased
1
Reduced
50
Closed
3
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRG
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
|
+$3.18M |
| 2 |
W.W. Grainger
GWW
|
+$506K |
| 3 |
Jacobs Solutions
J
|
+$399K |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$201K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITY
IMPERIAL TOBACCO GRP ADS(RP 2
ITY
|
+$6.4M |
| 2 |
RELX
RELX
|
+$5.17M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$2.6M |
| 4 |
CRH
CRH
|
+$2.04M |
| 5 |
Novartis
NVS
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 32.51% |
| 2 | Financials | 16.03% |
| 3 | Healthcare | 13.35% |
| 4 | Technology | 12.35% |
| 5 | Energy | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Diageo
DEO
$52.3B
| $8.06M | 4.31% |
72,884
-12,344
| -14% | -$1.42M |
2013 Q2
7 quarters
|
|
|
2
Novartis
NVS
$286B
| $7.46M | 3.99% |
84,403
-22,860
| -21% | -$2.03M |
2013 Q2
7 quarters
|
|
3
TE Connectivity
TEL
$61.7B
| $6.63M | 3.55% |
92,608
-18,608
| -17% | -$1.28M |
2014 Q4
1 quarter
|
|
4
WPP
WPP
$5.86B
| $5.89M | 3.15% |
51,813
-16,769
| -24% | -$1.88M |
2013 Q2
7 quarters
|
|
5
Mitsubishi UFJ Financial
MUFG
$246B
| $5.69M | 3.05% |
915,397
-91,276
| -9% | -$542K |
2013 Q2
7 quarters
|
|
6
SAP
SAP
$260B
| $5.69M | 3.04% |
78,793
-20,459
| -21% | -$1.4M |
2013 Q2
7 quarters
|
|
|
7
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $5.67M | 3.03% |
91,035
-44,662
| -33% | -$2.6M |
2013 Q2
7 quarters
|
|
8
Sanofi
SNY
$96.5B
| $5.62M | 3.01% |
113,648
-26,633
| -19% | -$1.27M |
2013 Q2
7 quarters
|
|
|
RDS.A
9
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.4M | 2.89% |
96,852
-22,735
| -19% | -$1.35M |
2013 Q2
7 quarters
|
|
|
AKZOY
10
DELISTED
Akzo Nobel NV
AKZOY
| $5.22M | 2.79% |
207,512
-57,737
| -22% | -$1.45M |
2013 Q2
7 quarters
|
|
11
TotalEnergies
TTE
$195B
| $5.19M | 2.78% |
104,487
-23,065
| -18% | -$1.18M |
2013 Q2
7 quarters
|
|
12
GSK
GSK
$98.2B
| $5.11M | 2.73% |
88,594
-20,723
| -19% | -$1.19M |
2013 Q2
7 quarters
|
|
|
SYT
13
DELISTED
Syngenta Ag
SYT
| $5.02M | 2.69% |
74,062
-22,707
| -23% | -$1.53M |
2013 Q2
7 quarters
|
|
|
AXA
14
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $5M | 2.67% |
198,119
-47,984
| -19% | -$1.21M |
2013 Q2
7 quarters
|
|
15
HSBC
HSBC
$323B
| $4.71M | 2.52% |
125,443
-8,385
| -6% | -$327K |
2013 Q2
7 quarters
|
|
|
CS
16
DELISTED
Credit Suisse Group
CS
| $4.6M | 2.46% |
170,806
-5,083
| -3% | -$121K |
2013 Q2
7 quarters
|
|
17
ING
ING
$94.5B
| $4.48M | 2.4% |
306,609
-25,250
| -8% | -$345K |
2014 Q3
2 quarters
|
|
18
Ericsson
ERIC
$34.8B
| $4.28M | 2.29% |
340,851
-94,299
| -22% | -$1.18M |
2013 Q2
7 quarters
|
|
|
ABB
19
DELISTED
ABB Ltd
ABB
| $4.09M | 2.19% |
193,234
-48,215
| -20% | -$992K |
2013 Q2
7 quarters
|
|
|
20
CRH
CRH
$54.8B
| $4.08M | 2.18% |
155,746
-78,291
| -33% | -$2.04M |
2013 Q2
7 quarters
|
|
21
BHP
BHP
$211B
| $3.67M | 1.96% |
93,403
-16,494
| -15% | -$670K |
2013 Q2
7 quarters
|
|
22
Barclays
BCS
$76B
| $3.39M | 1.81% |
250,528
-76,002
| -23% | -$1.06M |
2014 Q3
2 quarters
|
|
|
BRG
23
DELISTED
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
| $3.18M | 1.7% |
+257,567
| New | +$3.18M |
2015 Q1
0 quarters
|
|
|
MKTAY
24
DELISTED
MAKITA CORP SPONS ADR
MKTAY
| $2.99M | 1.6% |
57,332
-15,915
| -22% | -$829K |
2014 Q1
4 quarters
|
|
|
TKP
25
DELISTED
TECHNIP ADS (EA REPTG ONE ORD SHS)
TKP
| $2.88M | 1.54% |
190,358
-44,481
| -19% | -$673K |
2013 Q4
5 quarters
|
|
Similar funds
CC
RAM
ACI
QCM
NHG
RVGI
BS
BSCM
Northroad Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Northroad Capital Management held 59 positions worth $187M, down 16% from $221M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Northroad Capital Management withdrew a net $44.4M in Q1 2015, closing 3 positions and reducing 50 holdings. Its most notable exit was IMPERIAL TOBACCO GRP ADS(RP 2, an estimated $6.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Northroad Capital Management opened a new position in BG GROUP PLC ADS(RP 5 ORD SHS) worth $3.18M.
- Northroad Capital Management's largest Q1 2015 buy was BG GROUP PLC ADS(RP 5 ORD SHS): 257,567 shares worth $3.18M.
- Northroad Capital Management added most to Discovery, Inc. Series C Common Stock in Q1 2015, an estimated $201K increase.
- Northroad Capital Management's biggest Q1 2015 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $2.6M.
- Northroad Capital Management fully exited IMPERIAL TOBACCO GRP ADS(RP 2 in Q1 2015, selling an estimated $6.4M.
- Northroad Capital Management's ten largest holdings make up 34% of its $187M portfolio in Q1 2015.
- Northroad Capital Management opened 5 new positions and closed 3 in Q1 2015.
- Northroad Capital Management's portfolio value fell 16% quarter-over-quarter to $187M.
Based on Northroad Capital Management's 13F filing for Q1 2015, filed 14 May 2015.